» Articles » PMID: 21106245

Akt Cross-links IL-4 Priming, Stem Cell Factor Signaling, and IgE-dependent Activation in Mature Human Mast Cells

Overview
Journal Mol Immunol
Date 2010 Nov 26
PMID 21106245
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Challenge of human mast cells with both stem cell factor (SCF) and IL-4 enhances antigen-dependent mediator release raising the assumption of intracellular crosstalk between the IL-4, SCF, and FcɛRI signaling pathways. Here, we analyzed the intracellular crosstalk of IL-4-, SCF-, and IgE-dependent activation pathways in mucosal mast cells isolated from human intestine. The release of β-hexosaminidase, leukotriene C(4), and IL-8, but not IL-6, was strongly enhanced in response to sequential challenge of mast cells with IL-4, SCF and FcɛRI cross-linking compared to stimulation by FcɛRI cross-linking alone. Previous studies revealed that MAPK and other serine/threonine kinases are involved in mast cell activation processes. Here we found that activation of mast cells by FcɛRI cross-linking alone results in phosphorylation of ERK and p38, but not of Akt. Stimulation with SCF alone also induced phosphorylation of ERK and p38, and additionally of Akt. IL-4 priming enhanced activation of ERK, but blocked activation of p38. Activation of p38 was required for IL-6 production explaining the inhibitory effect of IL-4 on IL-6 expression in human mast cells. Moreover, IL-4 priming that anteceded FcɛRI cross-linking induced activation of Akt. The combined challenge of mast cells with IL-4, SCF and FcɛRI cross-linking substantially up-regulated activation of Akt, whereas blocking of Akt inhibited the pronounced production and release of IL-8 in response to the three mast cell agonists. In summary, our data demonstrate that ERK, p38, and especially Akt play an important role in cross-linking IL-4 priming, SCF signaling, and IgE-dependent activation of mature human mast cells.

Citing Articles

The Role of Stem Cell Factor, Epidermal Growth Factor and Angiopoietin-2 in HBV, HCV, HCC and NAFLD.

Radmanic L, Zidovec-Lepej S Life (Basel). 2022; 12(12).

PMID: 36556437 PMC: 9786337. DOI: 10.3390/life12122072.


Ataxin-3, The Spinocerebellar Ataxia Type 3 Neurodegenerative Disorder Protein, Affects Mast Cell Functions.

Sowa A, Haas E, Hubener-Schmid J, Lorentz A Front Immunol. 2022; 13:870966.

PMID: 35558088 PMC: 9086395. DOI: 10.3389/fimmu.2022.870966.


Protein Kinase C α and β compensate for each other to promote stem cell factor-mediated KIT phosphorylation, mast cell viability and proliferation.

Teegala L, Elshoweikh Y, Gudneppanavar R, Thodeti S, Pokhrel S, Southard E FASEB J. 2022; 36(5):e22273.

PMID: 35349200 PMC: 9298465. DOI: 10.1096/fj.202101838RRR.


Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management.

He L, Yi W, Huang X, Long H, Lu Q Clin Rev Allergy Immunol. 2021; 61(3):424-448.

PMID: 34529248 DOI: 10.1007/s12016-021-08886-x.


Resveratrol Is a Natural Inhibitor of Human Intestinal Mast Cell Activation and Phosphorylation of Mitochondrial ERK1/2 and STAT3.

Bilotta S, Paruchuru L, Feilhauer K, Koninger J, Lorentz A Int J Mol Sci. 2021; 22(14).

PMID: 34299258 PMC: 8307672. DOI: 10.3390/ijms22147640.